Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced Antithrombogenic Performance of Microfluidic Oxygenators through Dual Bioactive Surface Modification for an Artificial Placenta System.

Acta biomaterialia·2026
Same author

Individual Comparative PK Evaluation of Single-dose Octocog Alfa, Rurioctocog Alfa Pegol, and Efanesoctocog Alfa in Adults with Severe Hemophilia A.

TH open : companion journal to thrombosis and haemostasis·2026
Same author

Case Report: Atypical presentations of neonatal and infantile hemophilia B.

Frontiers in pediatrics·2026
Same author

Defining Roles in Pediatric Palliative Care: Perspectives From Oncology and Palliative Care Teams.

Pediatric blood & cancer·2026
Same author

Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors.

The New England journal of medicine·2026
Same author

An international survey on current practices of management of neonatal catheter-associated venous thromboembolism: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.

Journal of thrombosis and haemostasis : JTH·2026
Same journal

Mapping the 3D Chromosome Organization of a Biosynthetic Gene Cluster by Capture Hi-C (CHi-C).

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Mapping the 3D Chromosome Organization of Streptomyces by Hi-C.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

CUT&Tag Epigenomic Profiling of Biosynthetic Gene Clusters in Arabidopsis thaliana.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Rhizobium rhizogenes-Mediated Hairy Root Transformation Protocol for Lotus japonicus and Other Legumes.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Characterization of Bioactive Saponins from Sea Cucumbers.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for Functional Validation of Terpenoid Metabolic Clusters in Nicotiana benthamiana and Aspergillus oryzae.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jun 29, 2026

Accuracy in Dental Medicine, A New Way to Measure Trueness and Precision
07:57

Accuracy in Dental Medicine, A New Way to Measure Trueness and Precision

Published on: April 29, 2014

Thrombin generation.

Leslie R Berry1, Anthony K C Chan

  • 1Thrombosis and Atherosclerosis Research Institute (TaARI), McMaster University, Hamilton, ON, Canada.

Methods in Molecular Biology (Clifton, N.J.)
|April 3, 2013
PubMed
Summary
This summary is machine-generated.

Thrombin generation is key to blood clotting. New methods directly measure this potential in blood samples, offering a refined way to assess bleeding or clotting risks, though a standard test is still lacking.

More Related Videos

A Standardized Approach to Extra-Oral and Intra-Oral Digital Photography
06:49

A Standardized Approach to Extra-Oral and Intra-Oral Digital Photography

Published on: July 22, 2022

Semi-Automated Planimetric Quantification of Dental Plaque Using an Intraoral Fluorescence Camera
09:34

Semi-Automated Planimetric Quantification of Dental Plaque Using an Intraoral Fluorescence Camera

Published on: January 27, 2023

Related Experiment Videos

Last Updated: Jun 29, 2026

Accuracy in Dental Medicine, A New Way to Measure Trueness and Precision
07:57

Accuracy in Dental Medicine, A New Way to Measure Trueness and Precision

Published on: April 29, 2014

A Standardized Approach to Extra-Oral and Intra-Oral Digital Photography
06:49

A Standardized Approach to Extra-Oral and Intra-Oral Digital Photography

Published on: July 22, 2022

Semi-Automated Planimetric Quantification of Dental Plaque Using an Intraoral Fluorescence Camera
09:34

Semi-Automated Planimetric Quantification of Dental Plaque Using an Intraoral Fluorescence Camera

Published on: January 27, 2023

Area of Science:

  • Biochemistry
  • Hematology
  • Medical Diagnostics

Background:

  • Thrombin generation is central to in vivo coagulation.
  • Ex vivo thrombin generation markers aid in thrombosis detection.
  • Standard clot-time tests offer limited endpoint measures of hemostasis.

Purpose of the Study:

  • To review available thrombin generation tests.
  • To highlight a preferred technology for direct thrombin generation measurement.
  • To address the need for a consensus method in hemostasis assessment.

Main Methods:

  • Detailed procedures for current thrombin generation assays.
  • Emphasis on a specific preferred technology.
  • Discussion of methodologies for assessing procoagulant and anticoagulant parameters.

Main Results:

  • Thrombin generation potential measurement offers refined assessment of hemostatic status.
  • Existing methods vary, lacking a standardized approach.
  • Direct measurement provides more precise insights than traditional clot-time tests.

Conclusions:

  • Direct measurement of thrombin generation is a valuable tool for assessing hemostatic balance.
  • Standardization of thrombin generation assays is needed.
  • This review provides procedural details for available methods, guiding clinical application.